Document |
Document Title |
WO/1993/022273A1 |
Reaction of amine-containing substrates with hydrogen peroxide can suffer from certain problems, especially in the presence of transition metals. These problems include both in situ generation of impurities and particularly nitrosamines,...
|
WO/1993/011098A1 |
New compounds are described typically having the formula CH3C(CH2R)3 or ZCH2C(CH2R)3 where R is a fluorohydrocarbon or perfluorocarbon group preferably containing 4-16 carbon atoms and more F atoms than H atoms. Z is a hydrophilic group ...
|
WO/1993/011099A1 |
The invention provides nitroaniline derivatives represented by general formula (I) where the nitro group is substituted at any one of the available benzene positions 2-6; where R and A separately represent the groups NO2, CN, COOR1, CONR...
|
WO/1993/007114A1 |
There are disclosed cardiovascularly active compounds possessing antihypertensive properties, and pharmaceutical compositions containing these agents and a method of treating cardiovascular disorders with the compounds. The active compon...
|
WO/1993/003006A1 |
Novel perhydrates having utility as surfactants and bleaching agents are obtained by reacting an anhydrous amine oxide or an amine oxide monohydrate with hydrogen peroxide in such proportions as to provide a compound corresponding to the...
|
WO/1992/018469A1 |
Compounds of formula (I), in which R1 is CH=CHR, CH=NNHR, CH=N-A-N(O)R'R'' or CH2-NH-A-N(O)R'R'' and R2 is separately selected from hydrogen, CH=CHR, CH=NNHR, CH=N-A-(O)R'R'' and CH2-NH-A-N(O)R'R'', wherein A is a C2-4 alkylene group wit...
|
WO/1992/016197A1 |
Optically pure (S) metoprolol, which is substantially free of the (R) enantiomer, is a potent beta-blocker for treating myocardial infarction and for relieving the symptoms of angina pectoris, cardiac arrhythmia and hypertension in indiv...
|
WO/1992/016519A2 |
The invention describes liquid crystalline compounds of formula (I), where A, D and G are independently selected from phenyl, thiophene, hydrogenated phenyl, chlorinated phenyl and fluorinated phenyl, B and E are independently selected f...
|
WO/1992/013832A1 |
A solid amine oxide is prepared by reacting a tert-amine with at least a stoichiometric amount of an aqueous hydrogen peroxide having a concentration of at least 50 % by weight in the absence of any organic solvent to supplement the smal...
|
WO/1992/005149A1 |
There are disclosed novel complexes of nitric oxide and polyamines which are useful in treating cardiovascular disorders, including hypertension. The disclosed compounds release nitric oxide (endothelium-derived relaxing factor) under py...
|
WO/1991/019516A1 |
The invention relates to a metal-radionuclide complex comprising isonitrile ligands, said complex having general formula (I), wherein M is a metal-radionuclide selected from radioisotopes of Tc, Ru, Fe, Cr, Mn, Cu, Pb, Ga, As and In; R1 ...
|
WO/1991/018079A1 |
A pourable amine oxide composition which is suitable for use in detergent compositions is obtained by reacting a tert-amine with aqueous hydrogen peroxide in a normally liquid polyethylene glycol or a nonionic surfactant as the sole orga...
|
WO/1991/017143A1 |
The invention concerns diacylated dipercarboxylic acids according to general formula (I), in which R1 and R2 are hydrocarbon groups having from 1 to 15 carbon atoms, and X is electron attracting by being an optionally substituted phenyl ...
|
WO/1991/005552A1 |
Compositions containing as the active ingredient a spin-trapping reagent, preferably $g(a)-phenyl butyl nitrone (PNB), or spin-trapping derivatives thereof, in a suitable pharmaceutical carrier for administration to a patient, are disclo...
|
WO/1991/005824A1 |
Compounds of formula (I) in which R1, R2, R3 and R4 are each separately selected from hydrogen, X, NH-A-NHR and NH-A-N(O)R'R'' wherein X is hydroxy, halogeno, amino, C1-4 alkoxy or C2-8 alkanoyloxy, A is a C2-4 alkylene group with a chai...
|
WO/1991/005551A1 |
This invention concerns antihypertensive compositions and a method of lowering blood pressure in mammals. The active component of the composition is a compound of formula (I), wherein J is an organic or inorganic moiety, M+x is a pharmac...
|
WO/1991/004022A1 |
This invention concerns anti-hypertensive compositions and a method of lowering blood pressure in mammals. The active component of the compositions is a compound of formula (I), wherein R1 and R2 are independently chosen from straight ch...
|
WO/1990/012073A1 |
The invention concerns trifluoromethylcyclohexane derivatives of the formula (I) in which R, A?1¿, A?2¿, (a), Z?1¿, Z?2¿ and o are as defined in claim 1. These compounds can be used as components of liquid-crystal media for electro-o...
|
WO/1990/004585A1 |
A novel 2-imino derivative of an antifungal substance KA-7367A represented by formula (I) is disclosed. This derivative has a strong antifungal activity and an excellent stability, and is useful, for example, as an antifungal agent for w...
|
WO/1988/007514A1 |
Tolanes having the formula (I): R1-(A1-Z1)m-A3-C=C-A4-(A2)n-R2, in which R1, A1, Z1, m, A3, A4, A2, n and R2 are as given in claim (1), and application of said tolanes as components of liquid crystal phases, particularly as components of...
|
WO/1985/002173A1 |
Novel isomeric amine mixtures, characterized by amines with N-alkyl groups in the C10-C18 range with a main branch at the 2-position and moderate additional branching in most isomers. The amines are produced from lower olefins by a serie...
|
WO/1984/003883A1 |
A C-substituted or unsubstituted aryl-N-substituted or unsubstituted (branched alkyl or cycloalkyl) nitrone having anti-fatigue and/or antiozonant properties in rubber.
|
WO/1983/003761A1 |
A coordination complex of an isonitrile ligand and radionuclide such as Tc, Ru, Co, Pt, Fe, Os, Ir, W, Re, Cr, Mo, Mn, Ni, Rh, Pd, Nb and Ta, is useful as a diagnostic agent for labelling liposomes or vesicles, and selected living cells ...
|
WO/1981/001847A1 |
Tertiary amine oxides which comprise an amine oxide nucleus substituted with an organic group and with two hydroxy groups which have carbon atoms in at least the (Alpha) < (Beta) and (Alpha) positions, a hydroxyl group on the (Beta)-carb...
|
WO/1981/000106A1 |
An amine oxide foam stabilizer for stabilizing a foam of an alkyl benzene sulfonate foaming agent, wherein said amine oxide foam stabilizer is represented by the following general structure: (FORMULA) where, R1 is a C4-C11 alkyl group; R...
|
JP2024512568A |
Compounds and pharmaceutically acceptable salts and stereoisomers thereof suitable for the diagnosis and treatment of diseases and disorders characterized by, associated with, or indicative of tissue hypoxia, such as solid tumors, are di...
|
JP2024038014A |
The present invention provides a novel lipid and a composition containing the same. The nanoparticle compositions of the present disclosure include novel lipids and additional lipids such as phospholipids, structured lipids, and PEG lipi...
|
JP7432185B2 |
To provide a compound which forms an aggregate at low concentration and can further fully exhibit performance such as detergency.The invention provides a gemini compound represented by the general formula (1) in the figure, where R1 and ...
|
JP7372921B2 |
The present disclosure provides a polyetheramine alkoxylate compound containing aromatic groups in the hydrophobe allowing the compound to exhibit unique functionality, high performance and low cost, but without the toxicity and/or skin ...
|
JP2023534940A |
A branched surfactant for use in formulations and processes suitable for hydrocarbon recovery. These formulations include formulations suitable for fracking, oil and/or gas recovery enhancement, and bio-based oil recovery and/or producti...
|
JP2023534943A |
Agricultural products such as pesticides, plant growth regulators, fungicides, herbicides and insecticides may contain one or more branched surfactants, such as surface active properties, from one or more surfactant classes. can be formu...
|
JP2023534937A |
Such pre-texturing agents, etchants, and photoresist strippers comprise one or more branched-chain surfactants from one or more surfactant classes, such as derivatives of amino acids with surface-active properties. can be formulated. [Se...
|
JP7325560B2 |
The invention concerns new regulator compounds for a novel polymerization process for vinyl monomers, which yields polymers with improved control over composition and nearly full to full conservation of architectural integrity up to high...
|
JP2023534641A |
The present disclosure provides derivatives of amino acids having branched alkyl structures and surface active properties. Amino acids may be natural or synthetic amino acids, or may be obtained via ring-opening reactions of lactams such...
|
JP2023074480A |
To provide a nitration derivative based on human serum albumin (HSA)-binding compounds.The present invention provides a compound represented by the following chemical formula (where m and n each represent an integer of 1 to 7, and R repr...
|
JP7270935B2 |
Provided is a compound that thickens a fluid organic material to a desired viscosity and uniformly stabilizes composition thereof. A compound of the present invention is represented by Formula (1): where R1 represents a monovalent linear...
|
JP2023517665A |
Personal care products such as shampoos, conditioners, hair dyes, depilatory products, cleansers, cosmetics, mascaras, and toothpastes may contain one or more from one or more surfactant classes such as derivatives of amino acids with su...
|
JP2023517667A |
Inks, paints, adhesives, and paint strippers may be formulated to contain one or more surfactants from one or more surfactant classes, such as derivatives of amino acids with surface active properties. good. [Selection drawing] Fig. 1
|
JP2023512253A |
The present disclosure provides derivatives of amino acids that have surface active properties. Amino acids may be natural or synthetic amino acids, or may be obtained via ring-opening reactions of lactams such as caprolactam. Amino acid...
|
JP2023504723A |
TECHNICAL FIELD The present invention relates to an iridium complex suitable for use as a light emitter in an organic electroluminescence device.
|
JP7171510B2 |
The method for manufacturing an aromatic azo compound includes obtaining an azoxy compound by heating a mixture containing nitrobenzenes, an aldose, and an alkaline substance to a temperature of 25° C. to 50° C. under an alkaline condi...
|
JP7113441B2 |
The present invention provides a compound represented by formula (I) wherein symbols in the formula are as defined in the specification.
|
JP2022109444A |
To provide a method of producing nitrile oxide compound capable of producing a stabilized nitrile oxide compound with ease even in industrial scale.A method of producing a nitrile oxide compound represented by the following general formu...
|
JP7027320B2 |
The invention concerns new regulator compounds for a novel polymerization process for vinyl monomers, which yields polymers with improved control over composition and nearly full to full conservation of architectural integrity up to high...
|
JP6879523B2 |
This method is for producing a transition metal complex represented by formula (2), the method comprising reacting a compound containing a transition metal selected from V, Cr, Mo, W, Fe, Ru, Co, Rh, Ni, Pd, and Pt with an isocyanide com...
|
JP6871540B2 |
To provide a novel method for producing allylisocyanides.There is provided a method for producing allylisocyanides represented by a formula (II) and the like, where the method comprises reacting a cyanide such as trimethylsilyl cyanide w...
|
JP6825816B2 |
To provide a nitrile oxide compound that easily binds to a compound having an unsaturated bond and can provide the same with an amino acid or a peptide.Provided is a nitrile oxide compound having at least one amino acid moiety that may b...
|
JPWO2019059132A1 |
An object of the present invention is to provide a novel NF-κB inhibitor that is more effective, has higher bioavailability, and is more suitable for clinical application. More specifically, the present invention finds a non-epoxy compo...
|
JP2021006556A |
To provide a nitrile oxide compound which is easily synthesized, has high reactivity, but still has excellent storage stability at room temperature, and in which a nitrile oxide group is less likely to isomerize even at a high temperatur...
|
JPWO2019107450A1 |
A nitrile oxide compound represented by the general formula [I], having a melting point of 25 to 300 ° C. and a nitrile oxide equivalent of 1.0 to 4.5 mmol / g. [Chemical 1]s: Integer from 1 to 4, R1, R2: Hydrocarbon groups with 4 to 10...
|